Kissei Pharmaceutical FY net profit rises to Y13.78 billion
Updated
Updated · MarketWatch · May 11
Kissei Pharmaceutical FY net profit rises to Y13.78 billion
5 articles · Updated · MarketWatch · May 11
For the year ended 31 March, revenue increased to Y97.41 billion from Y88.33 billion and earnings per share rose to Y331.54 from Y274.21.
Despite higher net profit, the Japanese drugmaker posted an operating loss of Y2.93 billion versus a Y5.77 billion operating profit a year earlier, while pretax swung to a Y1.16 billion loss.
The figures, prepared under Japanese accounting standards, show bottom-line growth alongside weaker core profitability in FY2026 compared with FY2025.
How did Kissei boost net profit while its core operations lost billions?
Can Kissei's new drug Yselty® reverse its fortunes under Japan's price cuts?